ATA-100, a single-administration gene therapy candidate for LGMD2I/R9, delivers a normal copy of the gene for production of FKRP proteins. LGMD2I/R9 ...
https://www.google.com/url?rct=j&sa=t&url=https://www.bakersfield.com/ap/news/atamyo-therapeutics-announces-significant-milestones-for-ata-100-and-ata-200-its-gene-therapy-programs/article_8cb5448c-20f1-538a-9aa8-e218b3888a4a.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw1tJXHtWCvP8xHE33WM4FAd
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.